FHJ17813
Human
Human
IgG1, kappa
Monoclonal
APC
Klotho beta-like protein, KLB, Beta-klotho, BetaKlotho, BKL
0.5 mg/ml
Please contact with the lab for this information.
FCM
Liquid
0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.
Store at 4°C for 12 months. Protect from light. Do not freeze.
SAA0157
Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials., PMID:39805302
Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials., PMID:39805302
Fibroblast growth factor 21 alleviated atopic march by inhibiting the differentiation of type 2 helper T cells., PMID:39798471
Fibroblast growth factor 21 alleviated atopic march by inhibiting the differentiation of type 2 helper T cells., PMID:39798471
Therapeutic effects of FGF21 mimetic bFKB1 on MASH and atherosclerosis in Ldlr-/-.Leiden mice., PMID:39463193
Therapeutic effects of FGF21 mimetic bFKB1 on MASH and atherosclerosis in Ldlr-/-.Leiden mice., PMID:39463193
Liver-secreted FGF21 induces sarcopenia by inhibiting satellite cell myogenesis via klotho beta in decompensated cirrhosis., PMID:39226764
Degree of hydrolysis is a poor predictor of the sensitizing capacity of whey- and casein-based hydrolysates in a Brown Norway rat model of cow's milk allergy., PMID:38448113
Degree of hydrolysis is a poor predictor of the sensitizing capacity of whey- and casein-based hydrolysates in a Brown Norway rat model of cow's milk allergy., PMID:38448113
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells., PMID:38418879
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells., PMID:38418879
Simulation-based evaluation of personalized dosing approaches for anti-FGFR/KLB bispecific antibody fazpilodemab., PMID:38343040
Simulation-based evaluation of personalized dosing approaches for anti-FGFR/KLB bispecific antibody fazpilodemab., PMID:38343040
Allergenicity evaluation of quinoa proteins - A study in Brown Norway rats., PMID:37863384
Allergenicity evaluation of quinoa proteins - A study in Brown Norway rats., PMID:37863384
Algorithm for optimized mRNA design improves stability and immunogenicity., PMID:37130545
Algorithm for optimized mRNA design improves stability and immunogenicity., PMID:37130545
The Matrix-M™ adjuvant: A critical component of vaccines for the 21st century., PMID:37113023
The Matrix-M™ adjuvant: A critical component of vaccines for the 21st century., PMID:37113023
Precision cut intestinal slices, a novel model of acute food allergic reactions., PMID:36377289
Precision cut intestinal slices, a novel model of acute food allergic reactions., PMID:36377289
Evaluation of the Delivery of a Live Attenuated Porcine Reproductive and Respiratory Syndrome Virus as a Unit Solid Dose Injectable Vaccine., PMID:36366345
Evaluation of the Delivery of a Live Attenuated Porcine Reproductive and Respiratory Syndrome Virus as a Unit Solid Dose Injectable Vaccine., PMID:36366345
SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates against Symptomatic Infection., PMID:35856710
SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates against Symptomatic Infection., PMID:35856710
Selective Pharmaceutical Inhibition of PARP14 Mitigates Allergen-Induced IgE and Mucus Overproduction in a Mouse Model of Pulmonary Allergic Response., PMID:35817532
Selective Pharmaceutical Inhibition of PARP14 Mitigates Allergen-Induced IgE and Mucus Overproduction in a Mouse Model of Pulmonary Allergic Response., PMID:35817532
A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors., PMID:35655320
A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors., PMID:35655320
Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses., PMID:35263569
Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses., PMID:35263569
Results of a Phase 2b Trial With GB001, a Prostaglandin D2 Receptor 2 Antagonist, in Moderate to Severe Eosinophilic Asthma., PMID:35248549
Results of a Phase 2b Trial With GB001, a Prostaglandin D2 Receptor 2 Antagonist, in Moderate to Severe Eosinophilic Asthma., PMID:35248549
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice., PMID:33446655
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice., PMID:33446655
Antibody-mediated activation of the FGFR1/Klothoβ complex corrects metabolic dysfunction and alters food preference in obese humans., PMID:33139537
Antibody-mediated activation of the FGFR1/Klothoβ complex corrects metabolic dysfunction and alters food preference in obese humans., PMID:33139537
Single- and Multi-Arm Gadolinium MRI Contrast Agents for Targeted Imaging of Glioblastoma., PMID:32431501
Single- and Multi-Arm Gadolinium MRI Contrast Agents for Targeted Imaging of Glioblastoma., PMID:32431501
Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial., PMID:32034019
Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial., PMID:32034019
Increased Expression of FGF-21 Negatively Affects Bone Homeostasis in Dystrophin/Utrophin Double Knockout Mice., PMID:31800971
The Impact of Immunoglobulin G1 Fc Sialylation on Backbone Amide H/D Exchange., PMID:31581521
The Impact of Immunoglobulin G1 Fc Sialylation on Backbone Amide H/D Exchange., PMID:31581521
Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy., PMID:31462642
Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy., PMID:31462642
Macrophages express βKlotho in skin lesions of psoriatic patients and the skin of imiquimod-treated mice., PMID:30302794
Agonistic β-Klotho antibody mimics fibroblast growth factor 21 (FGF21) functions., PMID:30068552
Agonistic β-Klotho antibody mimics fibroblast growth factor 21 (FGF21) functions., PMID:30068552
A pharmacology guided approach for setting limits on product-related impurities for bispecific antibody manufacturing., PMID:29660397
A pharmacology guided approach for setting limits on product-related impurities for bispecific antibody manufacturing., PMID:29660397
Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice., PMID:29594879
Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice., PMID:29594879
A biparatopic agonistic antibody that mimics fibroblast growth factor 21 ligand activity., PMID:29483191
A biparatopic agonistic antibody that mimics fibroblast growth factor 21 ligand activity., PMID:29483191
FGF21 mimetic antibody stimulates UCP1-independent brown fat thermogenesis via FGFR1/βKlotho complex in non-adipocytes., PMID:29107292
FGF21 mimetic antibody stimulates UCP1-independent brown fat thermogenesis via FGFR1/βKlotho complex in non-adipocytes., PMID:29107292
FGF19, FGF21, and an FGFR1/β-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia., PMID:28988823
FGF19, FGF21, and an FGFR1/β-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia., PMID:28988823
Tethered-variable CL bispecific IgG: an antibody platform for rapid bispecific antibody screening., PMID:28985411
Tethered-variable CL bispecific IgG: an antibody platform for rapid bispecific antibody screening., PMID:28985411
FGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases., PMID:28525362
FGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases., PMID:28525362
Impact of antibody subclass and disulfide isoform differences on the biological activity of CD200R and βklotho agonist antibodies., PMID:28363871
Impact of antibody subclass and disulfide isoform differences on the biological activity of CD200R and βklotho agonist antibodies., PMID:28363871
A Novel Fc-FGF21 With Improved Resistance to Proteolysis, Increased Affinity Toward β-Klotho, and Enhanced Efficacy in Mice and Cynomolgus Monkeys., PMID:28324011
A Novel Fc-FGF21 With Improved Resistance to Proteolysis, Increased Affinity Toward β-Klotho, and Enhanced Efficacy in Mice and Cynomolgus Monkeys., PMID:28324011
An efficient route to bispecific antibody production using single-reactor mammalian co-culture., PMID:27680183
An efficient route to bispecific antibody production using single-reactor mammalian co-culture., PMID:27680183
Sustained Brown Fat Stimulation and Insulin Sensitization by a Humanized Bispecific Antibody Agonist for Fibroblast Growth Factor Receptor 1/βKlotho Complex., PMID:26288846
Sustained Brown Fat Stimulation and Insulin Sensitization by a Humanized Bispecific Antibody Agonist for Fibroblast Growth Factor Receptor 1/βKlotho Complex., PMID:26288846
Pharmacokinetics (PK), pharmacodynamics (PD) and integrated PK/PD modeling of a novel long acting FGF21 clinical candidate PF-05231023 in diet-induced obese and leptin-deficient obese mice., PMID:25790234
Pharmacokinetics (PK), pharmacodynamics (PD) and integrated PK/PD modeling of a novel long acting FGF21 clinical candidate PF-05231023 in diet-induced obese and leptin-deficient obese mice., PMID:25790234
Fibroblast growth factor 21 protects against high glucose induced cellular damage and dysfunction of endothelial nitric-oxide synthase in endothelial cells., PMID:25170746
Fibroblast growth factor 21 protects against high glucose induced cellular damage and dysfunction of endothelial nitric-oxide synthase in endothelial cells., PMID:25170746
Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study., PMID:25087476
Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study., PMID:25087476
Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer., PMID:22355336
Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer., PMID:22355336
Order: order@antibodysystem.com
Mail: support@antibodysystem.com
For research use only. Not for human or drug use.
Find out more about placing an order here
